Quick Answer
Elite Health Systems Inc. reported Diluted EPS of $0.17 per share (loss) for fiscal year 2023.
Elite Health Systems Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$0.17 | +0.0% |
| 2022 | -$0.17 | -54.5% |
| 2021 | -$0.11 | -257.1% |
| 2020 | $0.07 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| March 31, 2024 | -$0.03 | -200.0% | -50.0% |
| September 30, 2023 | -$0.02 | +50.0% | +60.0% |
| June 30, 2023 | -$0.05 | +64.3% | -400.0% |
| March 31, 2023 | -$0.01 | +80.0% | +75.0% |
| September 30, 2022 | -$0.04 | +20.0% | +71.4% |
| June 30, 2022 | -$0.14 | -75.0% | -180.0% |
| March 31, 2022 | -$0.05 | -225.0% | +0.0% |
| September 30, 2021 | -$0.05 | -350.0% | +37.5% |
- Elite Health Systems Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2023 period, Elite Health Systems Inc.’s diluted eps has declined by 342.9% (from $0.07 per share to $0.17 per share (loss)).
- The most recent figure is from Elite Health Systems Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 5, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: